NCT06913699
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 11 words
- Trial completed
- Primary completion date changed from estimate of Apr 30, 2026 to Oct 31, 2025
- Study description expanded, about 10 words
- Notable Eligibility criteria shortened, about 9 words
- Primary endpoints: 1 to 2
- Study description shortened, about 10 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Mertk expression levels of liver tissues
Timeframe: From enrollment to the end of treatment at 4 weeks
C-Kit expression levels of liver tissues
Timeframe: From enrollment to the end of treatment at 4 weeks
Arms and interventions
Procedures: Ultrasonund-guided percutaneous liver biopsy
Sites
1 site in 1 country
- Shanghai East Hospital (East Hospital Affiliated To Tongji University)Shanghai, Shanghai Municipality, China